During our 100+ years as a full-service, growth investment bank, we‘ve empowered our clients’ success by delivering a depth and breadth of insights across a broad range of sectors and capabilities.
Ahead of the Curve®
Oct 3, 2023
Back to School: Grading FDA Divisions on Regulatory Flexibility
Read More >
Ahead of the Curve®
Sep 19, 2023
Investors Guide to Immuno-Oncology
Read More >
May 5, 2023
Best ESG Investment Ideas for 2023
Read More >
Ahead of the Curve®
Mar 13, 2023
The Biotech Executive: Bold, Tenacious, And Accountable
Read More >
Ahead of the Curve®
Jan 27, 2023
The Price Is (Not) Right: Discounts, 340B, Access, And IRA
Read More >
Ahead of the Curve®
Nov 3, 2022
Profoundly Expanding the Target Space: A Primer on TPD
Read More >
Video
Ahead of the Curve®
Sep 27, 2022
Trials & Triumphs of the FDA: What Matters? Where are We?
Read More >
Ahead of the Curve®
May 31, 2022
Growing Up Ras: Resistance, Combos & Next Gen Agents
Read More >
Video
Mar 28, 2022
ESG Best Ideas 2022
Read More >
Ahead of the Curve®
Feb 17, 2022
ABCs of ADCs: Investor Primer on Antibody Drug Conjugates
Read More >
Ahead of the Curve®
Nov 16, 2021
Trials and Triumphs of Gene Editing: A Compendium
Read More >
Ahead of the Curve®
Sep 15, 2021
An Investor’s Guide to Bispecific Antibodies
Read More >
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.